FDA turns up the heat: Federal regulators are requesting more safety information from drugmakers on products meant to protect ...
Key milestone achieved as Company advances clinical program to full approval trial of ateganosine sequenced with a checkpoint inhibitor in ...
Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patients with rare diseases, today announced that the U.S. Food ...
Democratic senators have introduced a new bill to create a federal regulatory framework for hemp-derived cannabinoids and ...
Discusses Latest Phase III Updates for Azetukalner in Epilepsy and Commercial Launch Preparation December 10, 2025 ...
Enhertu (trastuzumab Deruxtecan [T-DXd]) treated patients continue to be eligible for enrollment in FLAMINGO-01. The Company believes that GLSI-100 will synergize with any trastuzumab based treatment ...
Discusses Clinical Progress of Lead Drug Candidates Targeting Parkinson's, Alzheimer's, and Liver Disease December 9, 2025 4:15 ...
In one popular YouTube video, an alleged flight attendant named Sophia warned passengers about TSA conducting "electronic ...
In some parts of the world, record numbers of people are being diagnosed with attention deficit hyperactivity disorder (ADHD) ...
Health Digest on MSN
Melania Trump's Favorite Soda Is Low In Calories But Full Of Artificial Sweeteners
Classy and private, Melania Trump often seems like the polar opposite of her husband, but she actually shares a similar ...
University leaders are clinging to “viewpoint diversity” and institutional neutrality in the face of MAGA assaults. This is a ...
Trump, during an interview with POLITICO’s Dasha Burns for a special episode of The Conversation, gave himself an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results